Atlas Trials

Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress

Clinical trial NCT04728698 · WITHDRAWN

Trial details

NCT number
NCT04728698
Sponsor
Sorrento Therapeutics, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19ARDS
Start date
2021-03-01
Primary completion
2021-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.